Victory Capital Management
LAB icon

Victory Capital Management’s Standard BioTools LAB Stock Holding History

Victory Capital Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.7K Buy
43,405
+1,230
+3% +$1.16K ﹤0.01% 2412
2026
Q1 		$38.8K Sell
42,175
-267
-0.6% -$323 ﹤0.01% 2332
2025
Q4 		$54.3K Buy
42,442
+335
+0.8% +$450 ﹤0.01% 2324
2025
Q3 		$54.7K Sell
42,107
-1,528
-4% -$2K ﹤0.01% 2333
2025
Q2 		$52.4K Sell
43,635
-614
-1% -$681 ﹤0.01% 2377
2025
Q1 		$47.8K Sell
44,249
-313
-0.7% -$439 ﹤0.01% 2370
2024
Q4 		$78K Sell
44,562
-1,319
-3% -$2.46K ﹤0.01% 2354
2024
Q3 		$88.5K Sell
45,881
-1,086
-2% -$2.13K ﹤0.01% 2341
2024
Q2 		$83.1K Buy
46,967
+10,067
+27% +$24.6K ﹤0.01% 2319
2024
Q1 		$100K Buy
36,900
+25,973
+238% +$62.7K ﹤0.01% 2305
2023
Q4 		$24.1K Buy
+10,927
New +$23.3K ﹤0.01% 2497
2021
Q3 		– Sell
-10,159
Closed -$63K – 2813
2021
Q2 		$63K Sell
10,159
-257
-2% -$1.37K ﹤0.01% 2653
2021
Q1 		$47K Sell
10,416
-262
-2% -$1.44K ﹤0.01% 2670
2020
Q4 		$64K Buy
+10,678
New +$70.2K ﹤0.01% 2445
2020
Q2 		– Sell
-8,664
Closed -$22K – 2902
2020
Q1 		$22K Buy
+8,664
New +$28.5K ﹤0.01% 2812
2019
Q4 		– Sell
-14,766
Closed -$68K – 2963
2019
Q3 		$68K Buy
+14,766
New +$116K ﹤0.01% 2564

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Victory Capital Management's LAB Position: Q2 2026 in Review

Victory Capital Management increased its Standard BioTools (LAB) stake by 2.9% in Q2 2026, buying an estimated $1.16K and bringing the position to 43,405 shares worth $35.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2412.

Victory Capital Management first reported a position in LAB in Q3 2019 and has held it in 16 quarters since. The position peaked at $100K in Q1 2024. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Victory Capital Management held 43,405 shares of Standard BioTools worth $35.7K as of Q2 2026.
  • Victory Capital Management bought 1,230 Standard BioTools shares in Q2 2026, an estimated $1.16K.
  • Standard BioTools made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2412 holding.
  • Victory Capital Management first reported a position in Standard BioTools in Q3 2019 and has held it in 16 quarters since.
  • Victory Capital Management's Standard BioTools position peaked at $100K in Q1 2024.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.